RESUMEN
X-ray fluorescence computed tomography (XFCT) is an emerging imaging modality that maps the three-dimensional distribution of elements, generally metals, in ex vivo specimens and potentially in living animals and humans. Building on our previous synchrotron-based work, we experimentally explored the use of a benchtop X-ray fluorescence computed tomography system for mapping trace-metal ions in biological samples. This system utilizes a scanning pencil-beam to stimulate the object and then relies on a detection system, with single or multiple slit apertures placed in front of position-sensitive X-ray detectors, to collect the fluorescence X-rays and to form 3-D elemental map without the need for tomographic imaging reconstruction. The technique was used to generate images of the elemental distributions of a triple-tube phantom and an osmium-stained zebrafish.
RESUMEN
This paper presents a feasibility study for using two new imaging geometries for synchrotron X-ray fluorescence emission tomography (XFET) applications. In the proposed approaches, the object is illuminated with synchrotron X-ray beams of various cross-sectional dimensions. The resultant fluorescence photons are detected by high-resolution imaging-spectrometers coupled to collimation apertures. To verify the performance benefits of the proposed methods over the conventional line-by-line scanning approach, we have used both Monte Carlo simulations and an analytical system performance index to compare several different imaging geometries. This study has demonstrated that the proposed XFET approach could lead to a greatly improved imaging speed, which is critical for making XFET a practical imaging modality for a wide range of applications.
RESUMEN
In this Letter the authors introduce a wide-field transmission ultrasound approach to breast imaging based on the use of a large area acousto-optic (AO) sensor. Accompanied by a suitable acoustic source, such a detector could be mounted on a traditional mammography system and provide a mammographylike ultrasound projection image of the compressed breast in registration with the x-ray mammogram. The authors call the approach acoustography. The hope is that this additional information could improve the sensitivity and specificity of screening mammography. The AO sensor converts ultrasound directly into a visual image by virtue of the acousto-optic effect of the liquid crystal layer contained in the AO sensor. The image is captured with a digital video camera for processing, analysis, and storage. In this Letter, the authors perform a geometrical resolution analysis and also present images of a multimodality breast phantom imaged with both mammography and acoustography to demonstrate the feasibility of the approach. The geometric resolution analysis suggests that the technique could readily detect tumors of diameter of 3 mm using 8.5 MHz ultrasound, with smaller tumors detectable with higher frequency ultrasound, though depth penetration might then become a limiting factor. The preliminary phantom images show high contrast and compare favorably to digital mammograms of the same phantom. The authors have introduced and established, through phantom imaging, the feasibility of a full-field transmission ultrasound detector for breast imaging based on the use of a large area AO sensor. Of course variations in attenuation of connective, glandular, and fatty tissues will lead to images with more cluttered anatomical background than those of the phantom imaged here. Acoustic coupling to the mammographically compressed breast, particularly at the margins, will also have to be addressed.
Asunto(s)
Acústica/instrumentación , Diagnóstico por Imagen de Elasticidad/instrumentación , Dispositivos Ópticos , Transductores , Ultrasonografía Mamaria/instrumentación , Diseño Asistido por Computadora , Diseño de Equipo , Análisis de Falla de Equipo , Fantasmas de Imagen , Reproducibilidad de los Resultados , Sensibilidad y EspecificidadRESUMEN
In this work, we propose a framework for optimizing spectral CT imaging parameters and hardware design with regard to material classification tasks. Compared with conventional CT, many more parameters must be considered when designing spectral CT systems and protocols. These choices will impact material classification performance in a non-obvious, task-dependent way with direct implications for radiation dose reduction. In light of this, we adapt Hotelling Observer formalisms typically applied to signal detection tasks to the spectral CT, material-classification problem. The result is a rapidly computable metric that makes it possible to sweep out many system configurations, generating parameter optimization curves (POC's) that can be used to select optimal settings. The proposed model avoids restrictive assumptions about the basis-material decomposition (e.g. linearity) and incorporates signal uncertainty with a stochastic object model. This technique is demonstrated on dual-kVp and photon-counting systems for two different, clinically motivated material classification tasks (kidney stone classification and plaque removal). We show that the POC's predicted with the proposed analytic model agree well with those derived from computationally intensive numerical simulation studies.
Asunto(s)
Dosis de Radiación , Tomografía Computarizada por Rayos X/métodos , Simulación por Computador , Ensayo de Materiales/métodos , Ensayo de Materiales/normas , Fantasmas de Imagen , Fotones , Tomografía Computarizada por Rayos X/normasRESUMEN
1. The effects of the inhibitors of endopeptidase EC 24.11, thiorphan and phosphoramidon administered i.c.v. (40 micrograms kg-1) i.p. (400 micrograms kg-1), or orally (400 micrograms kg-1), on intestinal motor activity in fed rats was compared to the effects of similar doses of the angiotensin converting enzyme inhibitor, captopril and the synthetic enkephalin analogue [D-Ala2 Met5] enkephalinamide (Dalamide). Drugs were administered alone or after pretreatment with naloxone or N-methyl levallorphan (300 micrograms kg-1, i.p.) given 10 min prior to gavage with a standard meal. 2. In control conditions, in the duodenum, the disruption of the migrating myoelectric complex (MMC) by gavage with a standard meal lasted between 105.6 and 119.1 min. This duration was significantly decreased by thiorphan (60.3 +/- 15.0 min), phosphoramidon (67.9 +/- 7.3 min), captopril (26.3 +/- 10.2 min) and Dalamide (42.4 +/- 9.6 min), administered i.c.v. 3. In contrast, after the i.p. administration of thiorphan, phosphoramidon and Dalamide the delay in the return of the MMC pattern was increased. Such an effect was also seen after the oral administration of phosphoramidon or Dalamide. Neither i.p. nor oral captopril administration altered the duration of postprandial pattern. 4. A prior treatment with naloxone i.p. (300 micrograms kg-1) that had no effect per se, antagonized the effect produced by i.c.v. administration of thiorphan, phosphoramidon or Dalamide, but failed to reverse the effect of captopril. In contrast, i.p. administration of N-methyl levallorphan (300pgkg-1) did not affect the response induced by central administration of thiorphan, phosphoramidon, captopril or Dalamide, but was able to prevent that of thiorphan, phosphoramidon or Dalamide when they were administered i.p. or orally. 5. These data strongly support the hypothesis of a dual control by endogenous opioids of intestinal motility in the rat: a central component that favours, and a peripheral control that delays the occurrence of the MMC profile in fed rats.
Asunto(s)
Endorfinas/fisiología , Motilidad Gastrointestinal/efectos de los fármacos , Administración Oral , Animales , Captopril/administración & dosificación , Captopril/farmacología , Electromiografía , Encefalina Metionina/administración & dosificación , Encefalina Metionina/análogos & derivados , Encefalina Metionina/farmacología , Glicopéptidos/administración & dosificación , Glicopéptidos/farmacología , Inyecciones Intraperitoneales , Inyecciones Intraventriculares , Levalorfano/administración & dosificación , Levalorfano/farmacología , Masculino , Naloxona/administración & dosificación , Naloxona/farmacología , Ratas , Ratas EndogámicasRESUMEN
The effects of treatment with CCK receptor antagonists or administration of an antisense oligonucleotide to the gastrin receptor, on gastrin-I and cholecystokinin-8-induced acid secretion in mouse stomach were evaluated. Administration of gastrin-I (1 microM) or cholecystokinin-8 (30 nM) stimulated acid output at the rates of 2.6 +/- 0.27 and 1.0 +/- 0.21 microEq h-1, respectively. Gastrin-I-induced acid output was significantly blocked by pretreatment of stomachs with 3R[+]-N-[2,3-dihydro-1-methyl-2-oxo-5- phenyl-1H-1,4-benzodiazepin-3-yl]-N[3-methylphenyl[urea (L-365,260; 1 microM), but not by devazepide (L-364,718; 1 microM). Cholecystokinin-8-induced acid output, on the other hand, was sensitive to both L-365,260 (100 nM) and L-364,718 (100 nM). Administration of antisense, but not mismatch, oligonucleotide significantly reduced gastrin-induced acid output, while antisense oligonucleotide treatment had no effect on cholecystokinin-8-induced acid output. These results of antagonist and antisense oligonucleotide studies suggest that gastrin-I and cholecystokinin-8 may involve different receptor subtypes in stimulating gastric acid secretion in mice, and that antisense oligonucleotide administration may serve an useful tool in characterizing CCK/gastrin receptor subtypes.
Asunto(s)
Ácido Gástrico/metabolismo , Mucosa Gástrica/metabolismo , Gastrinas/antagonistas & inhibidores , Oligonucleótidos Antisentido/farmacología , Compuestos de Fenilurea , Receptores de Colecistoquinina/genética , Sincalida/antagonistas & inhibidores , Animales , Secuencia de Bases , Benzodiazepinonas/farmacología , Devazepida , Determinación de la Acidez Gástrica , Gastrinas/farmacología , Antagonistas de Hormonas/farmacología , Masculino , Ratones , Ratones Endogámicos ICR , Datos de Secuencia Molecular , Ratas , Receptores de Colecistoquinina/antagonistas & inhibidores , Receptores de Colecistoquinina/biosíntesis , Sincalida/farmacología , Estómago/efectos de los fármacosRESUMEN
This study investigates the contribution of prostaglandins (PG) and calcitonin gene-related peptide (CGRP) pathways in visceral pain induced by peritoneal irritation in rats. Peritoneal irritation was produced by i.p. administration of acetic acid (AA: 0.06-1.0%, 10 ml/kg). Visceral pain was scored by counting abdominal contractions. The effect of CGRP (3-100 microg/kg, i.p.) was also evaluated. Like AA, CGRP induced abdominal pain. Neonatal pretreatment with capsaicin reduced abdominal contractions produced by AA (0.6%) and CGRP (20 microg/kg) with 64.6% and 45.6%, respectively. Abdominal contractions induced by AA and CGRP were blocked by two antinociceptive drugs, mu-and kappa-opioid agonists, morphine and (+/-)-U-50,488H, respectively. Indomethacin (3 mg/kg, s.c.) reduced the number of abdominal contractions produced by AA by 78.1%+/-6.4% but did not inhibit abdominal contractions produced by CGRP. The CGRP, receptor antagonist, hCGRP(8-37) (300 microg/kg, i.v.) inhibited AA- and CGRP-induced abdominal contractions with 57.5%+/-12.4% and 51.6%+/-11.3%, respectively. Concomitant i.p. administration of PGE1 and PGE2 (0.3 mg/kg of each) produced abdominal contractions which were inhibited 45.6%+/-9.3% by hCGRP(8-37) (300 microg/kg i.v.). Taken together, these results suggest that peritoneal irritation is likely to trigger the release of prostaglandins, which in turn produces a release of CGRP from primary sensory afferents.
Asunto(s)
Péptido Relacionado con Gen de Calcitonina/farmacología , Cólico/inducido químicamente , Prostaglandinas/metabolismo , Vísceras/efectos de los fármacos , 3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero , Ácido Acético/antagonistas & inhibidores , Analgésicos/farmacología , Animales , Antiinflamatorios no Esteroideos/farmacología , Péptido Relacionado con Gen de Calcitonina/antagonistas & inhibidores , Capsaicina/farmacología , Cólico/prevención & control , Relación Dosis-Respuesta a Droga , Indometacina/farmacología , Masculino , Morfina/farmacología , Dolor/inducido químicamente , Dolor/tratamiento farmacológico , Peritoneo/efectos de los fármacos , Pirrolidinas/farmacología , Ratas , Ratas Sprague-Dawley , Vísceras/inervaciónRESUMEN
Fedotozine, a kappa opioid agonist, reverses digestive ileus caused by acetic acid (AA)-induced visceral pain in rats. The aims of this study were: to map, in conscious rats, central pathways activated by AA using Fos as a marker of neuronal activation; to characterize primary afferent fibres involved in this activation; and to investigate the effect of fedotozine on AA-induced Fos expression. AA (0.6%; 10 mL kg-1) was injected i.p. in conscious rats either untreated; pretreated 14 days before with capsaicin; pretreated 20 min previously with fedotozine; or pretreated 2 h prior to fedotozine with the kappa-antagonist nor-binaltorphimine (nor-BNI). Controls received the vehicle alone. 60 min after injection of AA, rats were processed for Fos immunohistochemistry. Visceral pain was assessed by counting abdominal cramps. AA induced Fos in the thoraco-lumbar spinal cord (laminae I, V, VII and X) and numerous brain structures such as the nucleus tractus solitarius, and paraventricular nucleus (PVN) of the hypothalamus, whereas almost no Fos labelling was observed in controls. Capsaicin pretreatment blocked AA-induced Fos in all structures tested. Fedotozine significantly decreased AA-induced abdominal cramps and Fos immunoreactivity in the spinal cord and PVN, this effect being reversed by nor-BNI pretreatment. AA induces Fos in the spinal cord and numerous brain nucuei, some of which are involved in the control of digestive motility in rats. This effect is mediated through capsaicin-sensitive afferent fibres and prevented by fedotozine most likely through a peripheral action on visceral afferents.
Asunto(s)
Dolor Abdominal/metabolismo , Compuestos de Bencilo/farmacología , Encéfalo/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Genes fos , Obstrucción Intestinal/metabolismo , Propilaminas/farmacología , Proteínas Proto-Oncogénicas c-fos/biosíntesis , Receptores Opioides kappa/fisiología , Médula Espinal/efectos de los fármacos , Dolor Abdominal/inducido químicamente , Dolor Abdominal/prevención & control , Ácido Acético/administración & dosificación , Ácido Acético/antagonistas & inhibidores , Ácido Acético/toxicidad , Vías Aferentes/efectos de los fármacos , Animales , Compuestos de Bencilo/uso terapéutico , Encéfalo/metabolismo , Encéfalo/fisiopatología , Capsaicina/farmacología , Capsaicina/uso terapéutico , Inyecciones Intraperitoneales , Obstrucción Intestinal/inducido químicamente , Masculino , Naltrexona/análogos & derivados , Naltrexona/farmacología , Núcleo Hipotalámico Paraventricular/efectos de los fármacos , Núcleo Hipotalámico Paraventricular/metabolismo , Propilaminas/uso terapéutico , Ratas , Ratas Sprague-Dawley , Receptores Opioides kappa/agonistas , Receptores Opioides kappa/antagonistas & inhibidores , Núcleo Solitario/efectos de los fármacos , Núcleo Solitario/metabolismo , Médula Espinal/metabolismo , Médula Espinal/fisiopatología , Núcleo Supraóptico/efectos de los fármacos , Núcleo Supraóptico/metabolismoRESUMEN
This study compares the antinociceptive and orexigenic activities of NPY and analogs after intracerebroventricular administration in mice. NPY had an antinociceptive action in the mouse writhing test which was not affected by prior treatment with naltrexone, yohimbine, idazoxan or reserpine. A detailed examination revealed that NPY (0.023-0.7 nmol), PYY (0.007-0.07 nmol), NPY2-36 (0.023-0.23 nmol) and the Y1 agonist [Leu31, Pro34]-NPY (0.07-0.7 nmol) all produced a dose-dependent and complete suppression of acetic acid-induced writhing. In contrast, the Y2 agonist, NPY13-36, had little or no antinociceptive effect. As shown by their ED50 values, the relative potency of the peptides was PYY > NPY2-36 > or = NPY > [Leu31, Pro34]-NPY > > NPY13-36, suggesting that a Y1 rather than a Y2 or Y3 receptor subtype was implicated in the antinociceptive action. Thereafter, all peptides were assessed for their effects on food intake. With respect to dose and peptide specificity, the hyperphagic effects of NPY and related peptides paralleled those on nociception, suggesting a common receptor mechanism. However, a purported NPY antagonist, [D-Trp32]-NPY, attenuated NPY's effect on feeding yet this same peptide elicited a dose-dependent inhibition of acetic acid-induced writhing, suggesting some molecular distinction between antinociception and stimulation of food intake.
Asunto(s)
Neuropéptido Y/análogos & derivados , Neuropéptido Y/farmacología , Nociceptores/efectos de los fármacos , Fragmentos de Péptidos/farmacología , Antagonistas Adrenérgicos alfa/farmacología , Animales , Conducta Animal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos/efectos de los fármacos , Hormonas Gastrointestinales/farmacología , Idazoxan/farmacología , Inyecciones Intraventriculares , Masculino , Ratones , Péptido YY , Péptidos/farmacología , Receptores Adrenérgicos alfa 2/metabolismo , Receptores de Neuropéptido Y/metabolismo , Receptores Opioides/metabolismo , Yohimbina/farmacologíaRESUMEN
Fedotozine has been shown to act on gastrointestinal sensitivity through peripheral kappa-opioid receptors. The present study investigated the action of fedotozine and reference compounds, morphine and (+/-)-U-50,488H, on duodenal pain in anesthetized rats. The noxious stimulus was produced by duodenal distension (100 mm Hg; 30 s). Fedotozine (1-5 mg/kg i.v.) produced a dose-dependent inhibition of the cardiovascular reflex induced by duodenal distension (ED50 = 1.87 mg/kg) but had no effect at doses up to 300 micrograms/rat by either intracerebroventricular (i.c.v.) or intrathecal routes (i.t.). The mu-opioid receptor agonist, morphine, was active by both i.v. (ED50 = 0.62 mg/kg) and i.c.v. routes (ED50 = 2.17 micrograms/rat) as was the kappa-opioid receptor agonist, (+/-)-U-50,488H (trans-(+/-)-3,4-dichloro-N-methyl-N-(2-[1- pyrrolidinyl]cyclohexyl)benzeneacetamide) (ED50 = 0.25 mg/kg and 149 micrograms/rat for i.v. and i.c.v. routes, respectively). The selective kappa-opioid receptor antagonist, nor-binaltorphimine (10 mg/kg s.c.), abolished the response to fedotozine (5 mg/kg i.v.) and (+/-)-U-50,488H (2 mg/kg i.v.) but not that to morphine (1 mg/kg i.v.). In contrast, naloxone (30 micrograms/kg i.v.) blocked the response to morphine (1 mg/kg i.v.) but not that to fedotozine (5 mg/kg i.v.) or (+/-)-U-50,488H (2 mg/kg i.v.). It is concluded that the antinociceptive effects of fedotozine on duodenal pain are mediated by peripheral kappa-opioid receptors.
Asunto(s)
Analgésicos/farmacología , Compuestos de Bencilo/farmacología , Duodeno/fisiopatología , Dolor/fisiopatología , Propilaminas/farmacología , Receptores Opioides kappa/metabolismo , Reflejo/efectos de los fármacos , 3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero , Analgésicos/administración & dosificación , Animales , Presión Sanguínea/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Duodeno/efectos de los fármacos , Inyecciones Intravenosas , Inyecciones Intraventriculares , Masculino , Morfina/farmacología , Naloxona/farmacología , Naltrexona/análogos & derivados , Naltrexona/farmacología , Pirrolidinas/farmacología , Ratas , Ratas Sprague-Dawley , Receptores Opioides kappa/agonistasRESUMEN
Subcutaneous administration of granisetron (BRL 43694, endo-1-methyl-N-(9-methyl-9-azabicyclo[3.3.1.]non-3-yl-1 H-indazole-3-carboxamide) and zacopride (4-amino-N-(1-azabicyclo[2.2.2.]oct-3-yl)-5-chloro-2-methoxybenzamide), two 5-HT3 receptor antagonists, at doses ranging from 3 to 1000 micrograms/kg, inhibited abdominal contractions induced by distension (30 mmHg, 10 min) of irritated colon (0.6% acetic acid) in conscious rats with a bell-shaped dose-response curve. The ED50 of granisetron and zacopride were 17.6 and 8.2 micrograms/kg, respectively. In contrast, both tropisetron (ICS 205-930, (3-a-tropanyl)t-indole-3-carboxylic ester) and ondansetron (GR38032F, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1 H-imidazol-1-yl)methyl]-4 H-carbazol-4-one hydrocloride dihydrate) were inactive in this model. These data further support the concept of a heterogeneity in the potency of 5-HT3 receptor antagonists in modulating visceral hypersensitivity in conscious rats. This finding is in agreement with a reported efficacy of granisetron but not of ondansetron in patients with irritable bowel syndrome.
Asunto(s)
Colon/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Dolor/fisiopatología , Receptores de Serotonina/efectos de los fármacos , Antagonistas de la Serotonina/farmacología , Animales , Benzamidas/farmacología , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Colon/fisiopatología , Granisetrón/farmacología , Indoles/farmacología , Masculino , Contracción Muscular/efectos de los fármacos , Ondansetrón/farmacología , Ratas , Ratas Sprague-Dawley , Receptores de Serotonina 5-HT3 , TropisetrónRESUMEN
The mechanisms underlying the antinociception induced by morphine or U-50,488H (trans-(+-)-3,4-dichloro-N-methyl-N-(2-[1-pyrrolidinyl]- cyclohexyl)benzeneacetamide) against painful colonic distension were examined in anaesthetized rats. The respective ED50 values for morphine and U-50,488H were 0.34 and 0.35 mg/kg for the i.v. route, and 1.68 and 167 micrograms/rat for the i.c.v. route. Morphine was active by the intrathecal route (ED50 = 7.8 micrograms) whereas U-50,488H had no effect at doses up to 100 micrograms/rat. The morphine response was selectively antagonized by naloxone (30 micrograms/kg i.v.) whereas that of U-50,488H was blocked by nor-binaltorphimine (10 mg/kg s.c.). Bilateral vagotomy abolished the response to morphine at 0.35 mg/kg i.v. and reduced by 41.3% that to 1 mg/kg morphine, but had no effect on that to U-50,488H or i.c.v. morphine (10 micrograms/rat). It is concluded that peripheral mu- and kappa-opioid receptors may produce antinociception for colonic pain and that vagal integrity is required for mu-opioid but not kappa-opioid peripheral antinociception.
Asunto(s)
Analgésicos/farmacología , Colon/efectos de los fármacos , Morfina/farmacología , Dolor/tratamiento farmacológico , Pirrolidinas/farmacología , Nervio Vago/efectos de los fármacos , 3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero , Animales , Presión Sanguínea/efectos de los fármacos , Inyecciones Intraventriculares , Inyecciones Espinales , Masculino , Morfina/administración & dosificación , Naloxona/farmacología , Naltrexona/análogos & derivados , Naltrexona/farmacología , Neuronas Aferentes/efectos de los fármacos , Pirrolidinas/administración & dosificación , Ratas , Ratas Sprague-Dawley , Receptores Opioides kappa/efectos de los fármacos , Receptores Opioides kappa/metabolismo , Receptores Opioides mu/efectos de los fármacos , Receptores Opioides mu/metabolismo , Reflejo , Vagotomía , Nervio Vago/fisiologíaRESUMEN
The effect of fedotozine was evaluated in a model of colonic hypersensibility to balloon distension in anesthetized rats. Acetic acid (0.6%, intracolonically) significantly enhanced the hypotension reflex response to colonic distension (P < 0.05). At a noxious pain pressure (75 mm Hg), fedotozine ((+)-(-1R)-1-phenyl-1-[(3,4,5- trimethoxy)benzyloxymethyl]-N,N-dimethyl-n-propylamine) had no effect at 0.6 and 1 mg/kg i.v. in saline-treated rats and higher doses were required to produce antinociception (ED50 = 2.57 mg/kg i.v.). By contrast, fedotozine at 0.6 and 1 mg/kg i.v. displayed 38 and 54% antinociception (P < 0.05) respectively, in acetic acid-treated animals, leading to a decrease in its ED50 (1.15 mg/kg i.v.). Similar results were obtained with (+/-)-trans-N-methyl-N-[2-(pyrrolidinyl)-cyclohexyl]benzo[b]-thiophene- 4-acetamide (PD-117,302), a kappa-opioid receptor agonist, while the antinociceptive action of morphine and a kappa-opioid receptor agonist, trans-(+/-)-3,4-dichloro-N-methyl-N-(2-[1- pyrrolidinyl]cyclohexyl)benzenacetamide ((+/-)-U-50,488H), was identical in control and acetic acid-treated animals. Nor-binaltorphimine, a selective kappa-opioid receptor antagonist, reversed the enhanced antinociceptive activity of fedotozine and PD-117,302. It is concluded that acetic acid induces colonic hypersensibility to painful mechanical stimuli and that some but not all kappa-opioid receptor ligands can have enhanced efficacy in this pathological situation.
Asunto(s)
Compuestos de Bencilo/farmacología , Presión Sanguínea/efectos de los fármacos , Colon/efectos de los fármacos , Dolor/fisiopatología , Propilaminas/farmacología , Reflejo/efectos de los fármacos , 3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero , Acetatos , Ácido Acético , Secuencia de Aminoácidos , Anestesia , Animales , Colon/fisiología , Relación Dosis-Respuesta a Droga , Masculino , Datos de Secuencia Molecular , Pirroles/farmacología , Pirrolidinas/farmacología , Ratas , Ratas Sprague-Dawley , Tiofenos/farmacologíaRESUMEN
The effect of fedotozine on visceral hypersensitivity was evaluated in conscious rats. One hour after colonic irritation (0.6% acetic acid intracolonically), a 30 mmHg colonic distension was applied for 10 min. Irritation increased the number of abdominal contractions induced by colonic distension (23.4 +/- 4.1 versus 4.8 +/- 1.4 in saline-treated rats, P < 0.001). Facilitation of colonic pain was reversed in a dose-dependent manner by fedotozine ((+)-(-1R1)-1-phenyl-1-[(3,4,5-trimethoxy)benzyloxymethyl]-N ,N-dimethyl-n-propylamine), (+/-)-U-50,488H (trans-(+/-)-3,4-dichloro-N-methyl-N-(2-1-pyrrolidinyl]cyclohexyl)benzen eacetamide) and morphine (respective ED50 values 0.67, 0.51 and 0.23 mg/kg s.c.). The kappa-opioid receptor antagonist, nor-binaltorphimine, abolished the effects of fedotozine and (+/-)-U-50,488H but not those of morphine. Low doses of naloxone (30 microg/kg s.c.) blocked the effect of morphine but not of fedotozine or (+/-)-U-50,488H. After intracerebroventricular administration, morphine was very potent (ED50 1.7 microg/rat), (+/-)-U-50,488H poorly active (58% of antinociception at 300 microg/rat) and fedotozine inactive up to 300 microg/rat. These results show that fedotozine blocks hypersensitive visceral pain by acting on peripheral kappa-opioid receptors in animals.
Asunto(s)
Dolor Abdominal/tratamiento farmacológico , Compuestos de Bencilo/farmacología , Propilaminas/farmacología , Receptores Opioides kappa/efectos de los fármacos , 3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero , Analgésicos Opioides/administración & dosificación , Analgésicos Opioides/farmacología , Animales , Antihipertensivos/farmacología , Relación Dosis-Respuesta a Droga , Inyecciones Intraventriculares , Masculino , Morfina/administración & dosificación , Morfina/farmacología , Contracción Muscular/efectos de los fármacos , Pirrolidinas/farmacología , Ratas , Ratas Sprague-Dawley , Receptores Opioides kappa/agonistas , Receptores Opioides kappa/antagonistas & inhibidoresRESUMEN
Fedotozine is a kappa opioid receptor agonist having antinociceptive properties but devoid of diuretic effects. The aim of the study was to evaluate the discriminative stimulus effects of fedotozine at doses previously reported to produce maximal effects in in vivo assays measuring kappa-mediated analgesia. By using a two-lever drug discrimination task, two groups of rats were trained to discriminate either a 3 mg/kg i.p. dose of the kappa opioid agonist, U50,488, or a 5 mg/kg i.p. dose of the mu opioid agonist, morphine, from saline. Once trained, rats were used to conduct tests of stimulus generalization with morphine, U50,488 and fedotozine along with another kappa agonist, CI-977, and another mu agonist, fentanyl. The stimulus effect of U50,488 was shared by CI-977 but not by morphine. Conversely, the stimulus effect of morphine was shared by fentanyl but not by U50,488. Fedotozine (1-10 mg/kg) failed to substitute to either U50,488 or morphine. These results indicate that, when administered at doses fully effective in producing antinociception, the interoceptive stimulus effects of fedotozine, if any, can be distinguished from those produced by U50,488 and morphine.
Asunto(s)
3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero/farmacología , Analgésicos no Narcóticos/farmacología , Analgésicos Opioides/farmacología , Discriminación en Psicología/efectos de los fármacos , Morfina/farmacología , Receptores Opioides kappa/agonistas , Animales , Benzofuranos/farmacología , Compuestos de Bencilo/farmacología , Relación Dosis-Respuesta a Droga , Generalización del Estimulo , Masculino , Propilaminas/farmacología , Pirrolidinas/farmacología , Ratas , Ratas Long-EvansRESUMEN
It has recently been shown that longitudinal aliasing can be a significant and detrimental presence in reconstructed single-slice helical computed tomography (CT) volumes. This aliasing arises because the directly measured data in helical CT are generally undersampled by a factor of at least 2 in the longitudinal direction and because the exploitation of the redundancy of fanbeam data acquired over 360 degrees to generate additional longitudinal samples does not automatically eliminate the aliasing. In this paper we demonstrate that for pitches near 1 or lower, the redundant fanbeam data, when used properly, can provide sufficient information to satisfy a generalized sampling theorem and thus to eliminate aliasing. We develop and evaluate a Fourier-based algorithm, called 180FT, that accomplishes this. As background we present a second Fourier-based approach, called 360FT, that makes use only of the directly measured data. Both Fourier-based approaches exploit the fast Fourier transform and the Fourier shift theorem to generate from the helical projection data a set of fanbeam sinograms corresponding to equispaced transverse slices. Slice-by-slice reconstruction is then performed by use of two-dimensional fanbeam algorithms. The proposed approaches are compared to their counterparts based on the use of linear interpolation-the 360LI and 180LI approaches. The aliasing suppression property of the 180FT approach is a clear advantage of the approach and represents a step toward the desirable goal of achieving uniform longitudinal resolution properties in reconstructed helical CT volumes.
Asunto(s)
Análisis de Fourier , Tomografía Computarizada por Rayos X/instrumentación , Tomografía Computarizada por Rayos X/métodos , Algoritmos , Modelos Estadísticos , Fantasmas de Imagen , Reproducibilidad de los Resultados , Sensibilidad y EspecificidadRESUMEN
The influence of two enkephalinase inhibitors (thiorphan and acetorphan) orally, parenterally and centrally administered on food intake was tested in hay-fed ewes. When orally administered at a dose of 1 mg/kg, acetorphan, but not thiorphan, produced a biphasic increase in food intake corresponding to a 17.0% increase of daily food intake. Similarly thiorphan (0.1 mg X kg-1) IV administered increased by 19.3% the daily food intake; in contrast acetorphan IV administered produced a early (0-2 h) decrease followed by a late increase in hay consumption without significant (P greater than 0.05) change in the daily food intake. When ICV administered (10 micrograms X kg-1) thiorphan but not acetorphan at the same dose depressed the early (0-2 h) and daily food intake by 43.2% and 25.4% respectively. Pretreatment with naltrexone (0.1 mg X kg-1 IV) blocked the increased food intake induced by oral acetorphan or IV acetorphan and thiorphan but did not affect the anorectic effects of ICV thiorphan. We conclude that enkephalinase inhibitors like thiorphan and acetorphan increase daily food intake in sheep probably by increasing enkephalin levels in peripheral tissues.
Asunto(s)
Aminoácidos Sulfúricos/farmacología , Analgésicos/farmacología , Apetito/efectos de los fármacos , Inhibidores de Proteasas , Tiopronina/farmacología , Administración Oral , Animales , Ventrículos Cerebrales/efectos de los fármacos , Ventrículos Cerebrales/fisiología , Endopeptidasas , Femenino , Inyecciones Intravenosas , Inyecciones Intraventriculares , Neprilisina , Ovinos , Tiorfan , Tiopronina/administración & dosificación , Tiopronina/análogos & derivadosRESUMEN
The antinociceptive activity of the kappa- and mu-opioid receptor agonists, (+/-)-U-50,488H and morphine, was examined in a vaginal distension model in anaesthetized female rats. Vaginal distension induced a reproducible cardiovascular response (CVR) which was inhibited in a dose related manner by morphine (0.03-1.0 mg/kg i.v., ED50 = 0.16 mg/kg) and (+/-)-U-50,488H (0.08-1.6 mg/kg i.v., ED50 = 0.49 mg/kg). Morphine (0.3 microg/rat) administered i.c.v. inhibited the CVR by 81.6 +/- 7.9% whereas (+/-)-U-50,488H (30-300 microg/rat) was inactive by this route. A low dose of naloxone (30 microg/kg i.v.) blocked the effect of morphine but not that of (+/-)-U-50,488H. The kappa-opioid antagonist, nor-binaltorphimine (10 mg/kg s.c.) abolished the response to (+/-)-U-50,488H but not that of morphine. This demonstrates that both central and peripheral mu-opioid receptors may be involved in morphine-induced antinociception whereas the kappa-opioid agonist, (+/-)-U-50,488H, blocks vaginal nociception by acting on peripheral kappa-opioid receptors.
Asunto(s)
3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero/administración & dosificación , Analgesia , Anestesia , Morfina/administración & dosificación , Enfermedades Vaginales/fisiopatología , Analgésicos no Narcóticos , Analgésicos Opioides , Animales , Presión Sanguínea/efectos de los fármacos , Sistema Cardiovascular/efectos de los fármacos , Sistema Cardiovascular/fisiopatología , Estro/fisiología , Femenino , Naloxona/farmacología , Naltrexona/análogos & derivados , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Ratas , Ratas Sprague-Dawley , Receptores Opioides kappa/efectos de los fármacos , Receptores Opioides kappa/fisiología , Receptores Opioides mu/efectos de los fármacos , Receptores Opioides mu/fisiologíaRESUMEN
Peritoneal irritation in rats induced by i.p. administration of acetic acid produces abdominal contractions reflecting visceral pain, and gastrointestinal ileus characterized by inhibition of gastric emptying and small intestine transit. In this study, gastric emptying (GE) and intestinal transit, calculated by the geometric center (GC) method, were estimated using a test meal labeled with 51Cr-EDTA. Visceral pain was assessed by counting abdominal contractions. Acetic acid produced abdominal contractions (80.8 +/- 3.3) and inhibition of GE (-54%) and GC (-63%) during the test-period. The kappa-opioid receptor agonists, CI-977 (+/-)-U-50,488H, (+/-)-bremazocine, PD-117,302, (-)-cyclazocine, and U-69,583, reversed abdominal contractions and inhibitions of gastrointestinal transit in a dose-related manner. The mu-opioid receptor agonists and potent analgesics, morphine and fentanyl did not restore normal gastric emptying and intestinal transit. These data suggest that selective kappa-opioid receptor agonists might be used to treat abdominal pain associated with motility and transit impairment during postoperative ileus.
Asunto(s)
Analgésicos/farmacología , Seudoobstrucción Intestinal/tratamiento farmacológico , Dolor/tratamiento farmacológico , Receptores Opioides kappa/agonistas , 3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero , Ácido Acético/toxicidad , Animales , Benzofuranos/farmacología , Benzomorfanos/farmacología , Ciclazocina/farmacología , Fentanilo/farmacología , Vaciamiento Gástrico/efectos de los fármacos , Seudoobstrucción Intestinal/etiología , Masculino , Morfina/farmacología , Naloxona/farmacología , Naltrexona/análogos & derivados , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Dolor/etiología , Peritoneo/efectos de los fármacos , Pirroles/farmacología , Pirrolidinas/farmacología , Ratas , Ratas Sprague-Dawley , Receptores Opioides mu/agonistas , Tiofenos/farmacologíaRESUMEN
We develop and investigate an approach to tomographic image reconstruction in which nonparametric regression using a roughness-penalized Poisson likelihood objective function is used to smooth each projection independently prior to reconstruction by unapodized filtered backprojection (FBP). As an added generalization, the roughness penalty is expressed in terms of a monotonic transform, known as the link function, of the projections. The approach is compared to shift-invariant projection filtering through the use of a Hanning window as well as to a related nonparametric regression approach that makes use of an objective function based on weighted least squares (WLS) rather than the Poisson likelihood. The approach is found to lead to improvements in resolution-noise tradeoffs over the Hanning filter as well as over the WLS approach. We also investigate the resolution and noise effects of three different link functions: the identity, square root, and logarithm links. The choice of link function is found to influence the resolution uniformity and isotropy properties of the reconstructed images. In particular, in the case of an idealized imaging system with intrinsically uniform and isotropic resolution, the choice of a square root link function yields the desirable outcome of essentially uniform and isotropic resolution in reconstructed images, with noise performance still superior to that of the Hanning filter as well as that of the WLS approach.